Surmodics, Inc. (SRDX)
NASDAQ: SRDX · IEX Real-Time Price · USD
41.97
+0.07 (0.17%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Surmodics Revenue
Surmodics had revenue of $142.96M in the twelve months ending March 31, 2024, with 38.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $31.96M with 17.50% year-over-year growth. In the fiscal year ending September 30, 2023, Surmodics had annual revenue of $132.58M with 32.65% growth.
Revenue (ttm)
$142.96M
Revenue Growth
+38.84%
P/S Ratio
4.19
Revenue / Employee
$380,221
Employees
376
Market Cap
598.55M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 132.58M | 32.63M | 32.65% |
Sep 30, 2022 | 99.95M | -5.19M | -4.93% |
Sep 30, 2021 | 105.14M | 10.27M | 10.83% |
Sep 30, 2020 | 94.86M | -5.21M | -5.21% |
Sep 30, 2019 | 100.08M | 18.74M | 23.04% |
Sep 30, 2018 | 81.34M | 8.22M | 11.25% |
Sep 30, 2017 | 73.11M | 1.75M | 2.45% |
Sep 30, 2016 | 71.37M | 9.47M | 15.30% |
Sep 30, 2015 | 61.90M | 4.46M | 7.76% |
Sep 30, 2014 | 57.44M | 1.31M | 2.33% |
Sep 30, 2013 | 56.13M | 4.20M | 8.10% |
Sep 30, 2012 | 51.93M | -828.00K | -1.57% |
Sep 30, 2011 | 52.76M | -1.73M | -3.18% |
Sep 30, 2010 | 54.49M | -67.05M | -55.17% |
Sep 30, 2009 | 121.53M | 24.48M | 25.23% |
Sep 30, 2008 | 97.05M | 23.89M | 32.65% |
Sep 30, 2007 | 73.16M | 3.28M | 4.69% |
Sep 30, 2006 | 69.88M | 7.50M | 12.03% |
Sep 30, 2005 | 62.38M | 12.64M | 25.42% |
Sep 30, 2004 | 49.74M | 6.51M | 15.05% |
Sep 30, 2003 | 43.23M | 13.74M | 46.61% |
Sep 30, 2002 | 29.49M | 6.80M | 29.94% |
Sep 30, 2001 | 22.69M | 4.41M | 24.15% |
Sep 30, 2000 | 18.28M | 4.79M | 35.46% |
Sep 30, 1999 | 13.49M | 3.72M | 37.99% |
Sep 30, 1998 | 9.78M | 2.20M | 28.98% |
Sep 30, 1997 | 7.58M | 1.40M | 22.63% |
Sep 30, 1996 | 6.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pediatrix Medical Group | 2.00B |
Clover Health Investments | 1.85B |
Varex Imaging | 855.80M |
Fulgent Genetics | 287.53M |
Zymeworks | 50.46M |
SRDX News
- 22 days ago - Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. - Business Wire
- 4 weeks ago - SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX - Accesswire
- 4 weeks ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. - PRNewsWire
- 4 weeks ago - Shareholder Alert: Ademi LLP investigates whether Surmodics, Inc. has obtained a Fair Price for its Public Shareholders - PRNewsWire
- 4 weeks ago - SRDX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Surmodics, Inc. Is Fair to Shareholders - Business Wire
- 4 weeks ago - Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million - Business Wire
- 2 months ago - Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance - Business Wire
- 2 months ago - Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1 - Business Wire